Clinical systems available. Patient data protected.

Private providers, clinics, diagnostics businesses, medical device companies and life sciences organisations wherever they operate. Controls are mapped to the privacy and health data regime that applies to you, whether that is HIPAA, GDPR, POPIA or a comparable regime, rather than to a single country's rulebook.

Yes, where it applies. For covered entities and business associates we implement the administrative, physical and technical safeguards, hold the associated agreements, and keep the evidence a HIPAA audit or client due-diligence request will ask for. The same control set is remapped to GDPR, POPIA or local health data rules for organisations outside the United States.

Through classification, encryption in transit and at rest, least-privilege access with reviews, retention and deletion rules, and continuous monitoring, all recorded so the position can be evidenced.

We document where data lives, where it moves and on what legal basis, then set residency and transfer controls per entity. One control framework governs the group; the evidence pack is produced per jurisdiction.

We segment it. Unsupported or vendor-locked devices are isolated on controlled network segments with tightly scoped access and monitoring, so they remain usable without exposing the wider estate.

Layered detection and response, immutable backup copies, and restore rehearsals against clinical recovery objectives, so the decision in an incident is operational rather than financial.

Yes. We implement controlled sharing with partners and sponsors, including access expiry, audit trails and agreed handling rules for study data.

In administrative and operational workflows, yes, where it is registered, governed and human-reviewed. We do not deploy AI into clinical decision paths.

By clinical impact. Priority definitions are agreed with your leadership so systems affecting patient care outrank routine requests automatically.